ABSTRACT
International monitoring organizations call for child mortality indicators to be disaggregated by gender. However, there remains a paucity of studies, especially, from the sub-Saharan region aimed at producing accurate forecasts of child mortality indicators with their sex variations. This study aims at investigating disparities in indicators of childhood mortality rates by sex in Ghana by employing vector autoregressive (VAR) model to analyze jointly annual recorded data on total, male and female under-five mortality rates (TU5MR, MU5MR, FU5MR, respectively). The results show gradual declining under-five mortality trends among sexes in both the historical and forecasted rates. The trivariate traditional and instantaneous Granger causality analyses found that any of the mortality indicators Granger causes the other two combinations, except TU5MR to MU5MR and FU5MR. The forecast error variance decomposition analyses revealed that FU5MR was the most exogenous variable while long-term impulse response function analyses indicated that unit shocks in FU5MR significantly increased TU5MR. The VAR(2) model forecast constructed revealed that contrary to recent predictions based on wider interval data derived from demographic health surveys, Ghana may meet the SDG 3.2.2 if ongoing efforts are sustained and that focusing policies and interventions on reducing FU5MR would largely contribute to reducing TU5MR in Ghana.
Ethical considerations Not applicable. This study did not require ethics approval or consent for participation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
